Market Place
Sourcing Support
Insilico Nominates First Preclinical Drug in UAE Program
24 Apr 2026 //
PR NEWSWIRE BIO
Lilly Embraces AI Biotech Insilico Again, Inking $2.75B Collab
29 Mar 2026 //
FIERCE BIOTECH
Insilico, Tenacia Expand AI-Driven CNS Deal to $94.75M
26 Mar 2026 //
PR NEWSWIRE
Insilico Medicine Unveils Pandaclaw AI To Empower Biologists
23 Mar 2026 //
PR NEWSWIRE
Insilico, TaiGen Start Phase I Trial of ISM4808 for CKD Anemia
06 Mar 2026 //
PR NEWSWIRE
Insilico Medicine, Liquid AI Partner For Drug Discovery Models
03 Mar 2026 //
PR NEWSWIRE
Insilico, CMS Announce CNS and Autoimmune Disease Collaborations
10 Feb 2026 //
PR NEWSWIRE
Insilico Medicine Names Halle Zhang Vp, Clinical Development -
06 Feb 2026 //
PR NEWSWIRE BIO
Insilico Medicine Nominates ISM5059 as Preclinical Candidate
05 Feb 2026 //
PR NEWSWIRE
Insilico Gets USD 5M Milestone from Menarini for MEN2501 FIH
03 Feb 2026 //
PR NEWSWIRE
Insilico Medicine Nominates Ai-Powered GIPR Antagonist ISM0676
29 Jan 2026 //
PR NEWSWIRE
Qilu Inks $120M, AI-Enabled Cardiometabolic Pact With Insilico
27 Jan 2026 //
FIERCE BIOTECH
Insilico Medicine Gets FDA Nod For Ai-Backed NLRP3 Inhibitor
23 Jan 2026 //
PR NEWSWIRE BIO
Insilico Medicine Launches MMAI Gym To Elevate LLMs Into Pharma
22 Jan 2026 //
PR NEWSWIRE
Insilico Agrees To $66M Deal To Split Rights For NLRP3 Inhibitor
21 Jan 2026 //
FIERCE BIOTECH
Insilico, Hygtia Partner on NLRP3 Inhibitor
20 Jan 2026 //
PR NEWSWIRE
Insilico Doses First Patient in BETHESDA Trial for ISM5411
12 Jan 2026 //
PR NEWSWIRE
Insilico Medicine, Servier Partner For $888M Oncology Drug
04 Jan 2026 //
PR NEWSWIRE
Qiming Venture Partners` Insilico Medicine Lists On HKSE
31 Dec 2025 //
PR NEWSWIRE
Insilico Medicine Lists On Hkse, Leading AI Drug Discovery
30 Dec 2025 //
PR NEWSWIRE
Insilico Medicine Aims To Generate Nearly $300M In Hong Kong IPO
18 Dec 2025 //
FIERCE BIOTECH
Insilico & TaiGen Achieves License Agreement for CKD
12 Dec 2025 //
PR NEWSWIRE BIO
Insilico Medicine & Atossa Therapeutics Publish AI Study
02 Dec 2025 //
PR NEWSWIRE
Insilico Medicine Unveils AI-Driven PROTAC Targeting PKMYT1
02 Dec 2025 //
PR NEWSWIRE
Insilico, Lilly Partner For AI-Driven Drug Discovery
10 Nov 2025 //
FIERCE BIOTECH
ChemExpress Mabwell And Insilico Partner To Boost ADC Innovation
22 Sep 2025 //
PRESS RELEASE
Insilico Launches Nach01 on AWS for Gen AI Chemistry
10 Jun 2025 //
PR NEWSWIRE
Insilico Shares Ph 2a Rentosertib Data in Nat Med
03 Jun 2025 //
PR NEWSWIRE
Harbour BioMed & Insilico Partner For AI-Driven Antibody Discovery
20 Feb 2025 //
PR NEWSWIRE
Insilico posts benchmarks from 22 AI-designed drug candidates
12 Feb 2025 //
FIERCE BIOTECH
Insilico Reports Phase 1 Success For AI-Designed Drug In IBD
07 Jan 2025 //
PR NEWSWIRE
Generative Chemistry Drives PHD Inhibitors For Gut Mucosal Repair
11 Dec 2024 //
PR NEWSWIRE
Insilico Medicine to commence trials of ISM3312 in China to treat Covid-19
23 Feb 2023 //
CLINICAL TRIALS ARENA
Insilico opens largest AI-powered biotech research centre in Middle East
03 Feb 2023 //
BIOSPECTRUM ASIA
